Beroe
See the following -
Open Source Paradigm Could Swipe Biz From CROs: Beroe
Natalie Morrison | Outsourcing-Pharma.com | September 27, 2012
However “open source” drug discovery – by which a contractor buys a compound with little data, shares that data with a sponsor and then provides development services for a fee – could be a way to plug the gaps, Pakaravoor told us.
- Login to post comments